DHHS Adult ARV Guidelines
Interaction Color Code
Clinical Bottom Line
Do not coadminister: potentially increased levels of lomitapide
Drug 1
Drug 2
Mechanism
Inhibition of CYP3A4 by lenacapavir
Clinical Effects
Potential increased risk of lomitapide adverse effects
Management
Contraindicated. Use alternative agents
Info Source
